Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02679326
Other study ID # 4/2015
Secondary ID
Status Completed
Phase N/A
First received February 7, 2016
Last updated October 3, 2017
Start date May 2015
Est. completion date May 28, 2017

Study information

Verified date January 2017
Source Assuta Hospital Systems
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether Therapeutic Ultrasound is effective in the treatment of Plantar fasciitis (PF).


Description:

Plantar fasciitis (PF) is the main cause of pain in the bottom of the heel. According to the American Physical Therapy Association guidelines since 2008, many treatments have been described to correct the problem, but there are very few high level randomized trials that proved them. Although not mentioned even in clinical treatment guidelines in PF, one of the most common conservative treatments for use, in general and Israel in particular, is a therapeutic ultrasound device. Despite this widespread use, there are very few research evidence which examining the effectiveness of this device for the treatment of PF. The purpose of this study is to evaluate the effect of therapeutic ultrasound versus sham ultrasound on pain, function and quality of life of patients with PF. Our hypothesis is that the use of ultrasound parameters that cause an increase in the target tissue heat (from 1.75 to 1 W/cm2, Continues intensity of 1 MHZ) will result in a significant improvement than placebo. To evaluate this hypothesis, we will do a prospective, controlled, randomized, double-blind interventional clinical study. The study population will include 60 patients, aged 18 or older, suffering from PF and meet inclusion criteria. Subjects will be divided randomly into study or control group, Both groups will receive stretching Instructions, when the study group will Receive active ultrasound and the control group will Receive sham ultrasound. Both groups will receive 8 treatments, twice a week.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date May 28, 2017
Est. primary completion date May 28, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Worsening symptoms first steps in the morning or at the beginning of walking after sitting for long periods, and after long walking or standing.

- Pain at the bottom of the heel produced by weight bearing or local press.

- Pain level 3 or higher on NPRS at first steps in the morning.

- Tenderness, swelling, or both in the region of proximal plantar fascia and at medial plantar tuberosity of the calcaneous.

- Gradual development of pain at the bottom of the heel.

Exclusion Criteria:

- Peripheral neuropathy.

- Tarsal tunnel syndrome (TTS) \ Fat Pad Syndrome (FPS).

- Calcaneal cyst, Fracture or bone cancer.

- Osteo Arthritis (OA) of the foot fingers or Rheumatoid arthritis (RA).

- Foot surgery at the last year.

- Steroid injections at the last six months.

- Pregnancy.

- Foot infection or diabetic foot.

- Stress fractures of the heel.

- Unavailability in advance to participate in research.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Therapeutic ultrasound


Locations

Country Name City State
Israel Maccabee Health Services Physical therapy Clinic Rehovot Darom

Sponsors (1)

Lead Sponsor Collaborator
Assuta Hospital Systems

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numerical Pain Rating Scale (NPRS) at morning pain level at the heel at the first step in the morning. at morning after 4 weeks of treatment
Secondary NPRS during the day pain level during the day. 1 day
Secondary Foot & Ankle computerized adaptive test (CAT) Questionnaire of quality of life 2 & 4 weeks of treatment
Secondary Algometric test Average of 3 testing of Pressure on the medial tuberosity 4 weeks of treatment
See also
  Status Clinical Trial Phase
Completed NCT02546115 - RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis N/A
Terminated NCT01996111 - Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Unknown status NCT01882894 - Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment N/A
Completed NCT01659827 - Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis N/A
Completed NCT00758641 - Platelet Rich Plasma to Treat Plantar Fasciitis Phase 4
Completed NCT00888394 - Effectiveness of Podiatry on Plantar Pain Phase 4
Terminated NCT00527748 - Foot and Ankle Range of Motion (Stretching) Apparatus N/A
Recruiting NCT05584046 - A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF N/A
Completed NCT04088383 - Amnios™ RT Outcomes Study N/A
Completed NCT01994759 - Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof. Phase 4
Completed NCT02646579 - Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only N/A
Completed NCT05592808 - Comparison of Taping Techniques in Plantar Fasciitis N/A
Not yet recruiting NCT04125264 - Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis N/A
Completed NCT02546089 - ABI v Dry Needling for Plantar Fasciitis N/A
Completed NCT00765843 - A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain N/A
Completed NCT00155324 - Change and Clinical Significance of Plantar Fascia Thickness After ESWT N/A
Completed NCT04941469 - Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot N/A
Completed NCT06055933 - Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
Recruiting NCT02539082 - the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis Phase 4
Enrolling by invitation NCT01786057 - Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Phase 2/Phase 3